St. Louis, MO
Summary
This business focuses on developing pharmacological solutions to treat obesity and metabolic disorders by restoring natural heat production in the body, known as thermogenesis. Their innovative approach targets mitochondria to stimulate calorie burning, aiming to create a first-in-class drug that effectively addresses weight regulation beyond traditional dieting and exercise methods. The company employs advanced techniques to identify compounds that activate thermogenesis, with plans to expand into other mitochondrial therapeutic mechanisms.
Based on content on equatortherapeutics.com
No similar companies found
We offer API access to our data.
8 of 8 checks passed
Label
Value
Active Dates
4.8 years — Since Mar 2020
Web Hosting
Platform
E-Mail Provider
Google GSuite
NAICS Code
325412
SIC 4 Digit Code
2834
SIC 2 Digit Code
28
Industry
1. Biotechnology and Pharmaceuticals
2. Pharmaceutical Preparation Manufacturing
No vendors identified.
Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
---|---|---|---|---|---|---|---|---|---|---|---|---|
2020 |
|
|
|
|
|
|
|
|
|
|
|
|
2021 |
|
|
|
|
|
|
|
|
|
|
|
|
2022 |
|
|
|
|
|
|
|
|
|
|
|
|
2023 |
|
|
|
|
|
|
|
|
|
|
|
|
2024 |
|
|
|
|
|
|
|
|
|
|
|
|